search
Back to results

Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent.

Primary Purpose

Tay Sachs Disease, Canavan Disease, Familial Dysautonomia

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Online pre-test genetic education tool
Sponsored by
McGill University Health Centre/Research Institute of the McGill University Health Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Tay Sachs Disease focused on measuring Genetic Counseling, Technology, Ashkenazi Jewish, Carrier screening

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • At least one grandparent of Ashkenazi Jewish descent
  • Access to computer at home and computer literate

Exclusion Criteria:

  • Participant or participant's partner is pregnant at time of study
  • Family history of an Ashkenazi Jewish genetic condition

Sites / Locations

  • Montreal General Hospital (MUHC)

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

In-person counselling

Online pre-test genetic education tool

Arm Description

Similar to standard of care, wherein Ashkenazi Jewish individuals seeking carrier genetic screening meet a genetic counsellor for an in-person education and counselling session.

Use of a web-based pre-test education program, wherein the information from a typical genetic counselling session for carrier screening in Ashkenazi Jewish individuals is presented.

Outcomes

Primary Outcome Measures

Knowledge of Ashkenazi Jewish genetic conditions
Evaluated by questionnaire developed specifically for this study.

Secondary Outcome Measures

Patient anxiety
Evaluated by 6-item short form state trait anxiety inventory (Becker and Marteau 1992)
Satisfaction with web-based/in-person genetic counselling
Assessed by questionnaire, developed from pre-existing genetic counselling research (Shiloh et al. 1990; Yip et al. 2003)
Perceived risk of having a child with an Ashkenazi Jewish genetic condition
Evaluated by questionnaire developed specifically for this study.

Full Information

First Posted
November 25, 2013
Last Updated
August 14, 2017
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT01999257
Brief Title
Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent.
Official Title
Assessing the Outcomes of Web-based Pre-test Educational Module for Carrier Genetic Screening in Individuals of Ashkenazi Jewish Descent
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
July 2014 (undefined)
Primary Completion Date
April 2015 (Actual)
Study Completion Date
August 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators have developed a new website to educate persons of Ashkenazi Jewish ancestry about their increased risk for having children with certain genetic conditions, and the genetic testing the investigators offer. This study aims to pilot the website to find out whether it is effective and to learn what the investigators can improve. Participants in the study will be assigned to one of two conditions: Standard in-person genetic counselling session to learn about inheritance of Ashkenazi Jewish genetic conditions and genetic testing. Participants will fill out two short questionnaires, one before and one after the genetic counselling session. They will then be given a requisition form to undergo blood draw for genetic testing at the Montreal General Hospital test centre. Use of a web-based pre-test genetic counselling tool to learn about inheritance of Ashkenazi Jewish genetic conditions and genetic testing. They will fill out two short questionnaires, one before, and one after using the web-based tool. They will then be electronically sent a requisition form to undergo blood draw for genetic testing at the Montreal General Hospital test centre. In both conditions, genetic test results will be communicated by telephone once they are available. Participants' genetic test results will not be used in any way for the study.
Detailed Description
In Montreal, individuals of Ashkenazi Jewish descent are eligible to have carrier screening for three genetic conditions: Tay-Sachs disease, Canavan disease, and familial dysautonomia. The investigators have developed a new website to educate persons of Ashkenazi Jewish ancestry about their increased risk for having children with these genetic conditions, and the genetic testing the investigators offer. This study aims to pilot the website to find out whether it is effective and to learn what the investigators can improve. Specifically, the investigators will measure knowledge acquisition, level of anxiety, and degree of satisfaction with their experience. Participants in the study will be assigned to one of two conditions: Standard in-person genetic counselling session to learn about inheritance of Ashkenazi Jewish genetic conditions and genetic testing. Participants will fill out two short questionnaires, one before and one after the genetic counselling session. These questionnaires assess demographic information, knowledge regarding the three genetic conditions listed above, feelings and anxiety levels, e-health literacy, and overall satisfaction. They will then be given a requisition form to undergo blood draw for genetic testing at the Montreal General Hospital test centre. Use of a web-based pre-test genetic counselling tool to learn about inheritance of Ashkenazi Jewish genetic conditions and genetic testing. They will fill out two short questionnaires, one before, and one after using the web-based tool. These questionnaires are similar to those in the condition above, except there will also be questions regarding the utility of the web-based tool and ways to improve the tool. Participants will then be electronically sent a requisition form to undergo blood draw for genetic testing at the Montreal General Hospital test centre. In both conditions, genetic test results will be communicated by telephone once they are available. Participants' genetic test results will not be used in any way for the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tay Sachs Disease, Canavan Disease, Familial Dysautonomia
Keywords
Genetic Counseling, Technology, Ashkenazi Jewish, Carrier screening

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
In-person counselling
Arm Type
No Intervention
Arm Description
Similar to standard of care, wherein Ashkenazi Jewish individuals seeking carrier genetic screening meet a genetic counsellor for an in-person education and counselling session.
Arm Title
Online pre-test genetic education tool
Arm Type
Active Comparator
Arm Description
Use of a web-based pre-test education program, wherein the information from a typical genetic counselling session for carrier screening in Ashkenazi Jewish individuals is presented.
Intervention Type
Other
Intervention Name(s)
Online pre-test genetic education tool
Intervention Description
See Arm Descriptions above.
Primary Outcome Measure Information:
Title
Knowledge of Ashkenazi Jewish genetic conditions
Description
Evaluated by questionnaire developed specifically for this study.
Time Frame
1 hour
Secondary Outcome Measure Information:
Title
Patient anxiety
Description
Evaluated by 6-item short form state trait anxiety inventory (Becker and Marteau 1992)
Time Frame
1 hour
Title
Satisfaction with web-based/in-person genetic counselling
Description
Assessed by questionnaire, developed from pre-existing genetic counselling research (Shiloh et al. 1990; Yip et al. 2003)
Time Frame
1 hour
Title
Perceived risk of having a child with an Ashkenazi Jewish genetic condition
Description
Evaluated by questionnaire developed specifically for this study.
Time Frame
1 hour

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: At least one grandparent of Ashkenazi Jewish descent Access to computer at home and computer literate Exclusion Criteria: Participant or participant's partner is pregnant at time of study Family history of an Ashkenazi Jewish genetic condition
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guillaume Sillon, MSc
Organizational Affiliation
McGill University Health Centre/Research Institute of the McGill University Health Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Montreal General Hospital (MUHC)
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3G 1A4
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Publication of study results in a peer-reviewed journal.

Learn more about this trial

Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent.

We'll reach out to this number within 24 hrs